Key facts
- Brainvivo’s last known valuation is $20.2M (Jun 2021).
- It has raised $8.0M; the latest was Later Stage VC in Jun 2025.
- Notable investors include iAngels, Corner Ventures, Eitan Reisel, Elad Kushnir, HiCenter — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Brainvivo
- ·The full record, as it builds
Funding rounds
No funding rounds for Brainvivo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brainvivo
Developer of a brain-based intelligence technology designed to digitize and simulate human cognition and expertise. The company offers AI-driven brain modeling that replicates human thinking patterns, neural data encoding that transforms brain activity and real-world data into structured digital models, and foundation models built from digitized expert knowledge that capture and scale human expertise, enabling researchers, developers, and professionals to access, analyze, and apply human intelligence at scale while creating advanced tools and applications powered by cognitive insights.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2016
- Employees
- 13
- Website
- brainvivo.com/
- Ownership
- Privately Held (backing)
Brainvivo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brainvivo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brainvivo in its N-PORT filings yet. We sweep new filings monthly.